Skip to main content

Closed

CBUS: Cibus, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+134.6% / yr

Operating margin-1375.7%

ROIC-18.8%

Financially safe

Stretched

Debt / equity7.78×

Interest coverage-3.3×

Current ratio2.37×

Cibus, Inc.

CBUSNASDAQ·USD·Closed

Cibus, Inc.

CBUSNASDAQ·USD·Closed

$1.93

+0.00%

$1.93

+$0.00 (0.00%)

52W Range

27thpctl

Volume

0.40×avg

Mkt Cap

87.79MUSD

P/E

-1.1TTM

Div Yield

–ann

52W Range

27thpctl

Volume

0.40×avg

Market Cap

87.79MUSD

P/E Ratio

-1.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings